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Abstract 
Due to the claimed public health concerns, use of antibiotics as growth promoters (AGP) in the 
chicken feed is banned or regulated in several jurisdictions. Therefore, probiotics, prebiotics, and 
synbiotics are being evaluated as effective alternatives to AGP to improve growth performance 
and health of poultry. This study aimed to investigate the effects of Bacillus coagulans, Raffinose 
family oligosaccharides (RFO) and their combination on growth performance and gut health of 
broilers when injected in ovo. A total of 285 fertilized eggs were divided into 5 groups: i) No-
injection group with intact shell, ii) 0.5 ml 0.85% normal saline, iii) Probiotic (B. coagulans) 
(2×106 CFU/egg) in 0.5 ml 0.85% normal saline, iv) Prebiotic (4.5 mg RFO) in 0.5 ml 0.85% 
normal saline, and v) Synbiotic (2×106 CFU/egg B. coagulans + 4.5mg RFO) in 0.5 ml 0.85% 
normal saline. The injection solution was deposited into the amniotic sac on d 17 of incubation. 
Hatchability of eggs were recorded. Altogether, 48 day-old chicks from each treatment were 
randomly allocated to 6 replicate floor pens (n=8/pen). All birds were raised on a standard 
commercial diet and management for 42 days. Body weight and feed intake of birds were measured 
weekly. Ileum samples were collected on d 0 and d 7 post hatch for total RNA isolation. Expression 
of immune/cytokines related genes in the ileum were determined using qPCR. The in ovo injection 
did not affect (P > 0.05) hatchability of eggs across the treatments. There was no significant effect 
of treatments on body weight, average daily gain and feed intake of broilers in different 
experimental groups. However, birds from normal saline treatment had significantly better (P < 
0.05) feed efficiency and RFO group had the poorest feed efficiency in the first week of post-hatch 
period. No significant difference (P > 0.05) was found on relative organ weight of birds on d 21 
and d 42. At d 7 of age, ileum villus height, crypt depth, and villus height: crypt depth ratio of 
RFO group were significantly better than other treatments (P < 0.05). On hatch day, expression of 
 4 
IL4 (inducer of T-cells differentiation) was significantly higher (P < 0.001) in the ileum of 
probiotic group. On d 7, immune-related genes (CD56, ChB6, TLR4, MCN2) and cytokines related 
gene (IL10) were significantly higher (P < 0.05) in the ileum of saline-treated group, whereas 
glucose transporter (SGLT1) had lower expression (P < 0.05) in synbiotic group. In conclusion, in 
ovo injection of probiotic enhances gut immunity of chicken which would be beneficial for gut 
health. It is interesting to find that in ovo injection of saline also enhanced gut immunity.   
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CHAPTER 1: LITERATURE REVIEW 
 
1.1 Status of industry production 
By 2050 the world’s population will grow to more 9 billion, while patterns of food consumption 
are becoming more similar across the globe, shifting towards higher quality and more expensive 
foods such as meat and dairy products. Meat consumption in developing countries has risen from 
only 10 kg per person annually in 1964-66 to 26 kg in 1997-99. FAO expects that it is projected 
to rise to 37 kg per person per year in 2030 (FAO, 2010). Therefore, there is increasing demand 
for animal products, and growing consumer demands for more food safety, lower environmental 
impact, and better animal welfare conditions. 
Poultry industry already become a leader in trends of industrialization in agriculture over the last 
50 years for its highly specialized and efficient set of enterprises. In 2014, the U.S. poultry industry 
produced 8.54 billion broilers, 99.8 billion eggs, and 238 million turkeys. The combined value of 
production from broilers, eggs, turkeys, and the value of sales from chickens in 2014 was $48.3 
billion, up 9 percent from $44.4 billion in 2013 (NASS, 2015). Compared to other meat animals 
like swine, cattle, lamb, poultry converts feedstuff to feed more efficiently. The feed conversion 
ratio of broilers can reach 1.8-2.2; As the short period requirements on growth and marketing, the 
poultry industry is dynamic, which can adjust rapidly to changing economic factors (feed, 
availability, cost, number of birds on feed). Other livestock industries require a longer length of 
time from birth to market like cattle. Poultry is more straightforward to feed, kind of by-product 
can feed to poultry, for example, blood meal, fish meal, meat and bone, distillers grains. And it not 
used for human consumption. Except for meat, poultry- layers also provided a continuous source 
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of food. Meat animals must be fed for a longer period. Layers produce several times its weight in 
eggs. Products form meat animals are restricted to final market weight. For the reason of religion, 
and in some countries, meat eaters are the minority, vegetarians consume eggs. From the marketing 
view, poultry products are relatively inexpensive, and poultry meats are one of the best meat buys 
in the supermarket. Poultry manure as fertilizer, organic farming, premium price, rich in Nitrogen 
and organic material, by-product feed for ruminants. All the above reason makes poultry industry 
becoming a more essential part in the whole agriculture industry. However, with the increasing 
human worries about meat consumption and food safety, many factors that will influence the 
evolution of the poultry industry in this coming decade. Technical considerations and the evolution 
of science and technology, the availability of natural resources and water (which are becoming 
increasingly limited), and the maintenance of trade barriers must be considered. Finally, consumer 
demands will have a strong influence as these demands are becoming increasingly concerned with 
animal welfare issues, food safety, and environmental impact relative to poultry production. New 
methods to assess the economic and environmental impact of poultry production have been 
developed. For the future of the poultry industry, the expectation of increasing biotechnology, (in 
ovo inject), mass production, increase attention to poultry behavior and welfare, enhance food 
safety and quality of products. 
Antibiotics have been widely used in poultry production for decades, first primarily to control 
disease, and more recently as antimicrobial growth performance promoters (AGPs) to improve 
growth rate and feed conversion efficiency. However, it’s use has been banned in many countries 
and has been severely limited, or will be eliminated as public health concern. This has been a 
challenge for animal nutrition increasing the need to ﬁnd alternative methods to control and 
prevent pathogenic bacterial colonization. Ideally, alternatives to growth promoters should have 
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the same beneficial effect as AGPs. The most well-known mechanism to be proposed is that AGPs 
have antibacterial action that favours performance in different ways: 1) by reducing the incidence 
and severity of subclinical infections; 2) by reducing the microbial use of nutrients; 3) by 
improving absorption of nutrients because of thinning of the intestinal wall, and 4) by reducing the 
amount of growth-depressing metabolites produced by gram-positive bacteria (Huyghebaert et al., 
2010). For that, several alternatives to AGP have been attempted with some success, such as 
organic acids, probiotics, prebiotics, essential oil compounds, and enzymes. 
The modulation of the gut microbiota with new feed additives, such as probiotics and prebiotics, 
towards host-protecting functions to support animal health, is a topical issue in poultry production. 
Although the knowledge on the effects of such feed additives has increased, essential information 
concerning their impact on the host are, to date, incomplete. For the future, the most important 
target, within probiotic and prebiotic research, is a demonstrated health-promoting beneﬁt 
supported by knowledge on the mechanistic actions. Potential combinations of suitable probiotics 
and prebiotics may prove to be the next step to reduce the risk of intestinal diseases and remove 
speciﬁc microbial disorders (Gaggia et al., 2010).  
 
1.2 Probiotic 
1.2.1 Classification 
Probiotics used in animals are known as direct-fed microbial, many definitions have been proposed 
for the term. The more widely accepted and adopted one is “live micro-organisms which when 
administered in adequate amounts confer a health benefit on the host” (FAO/WHO, 2001). There 
are several different methods to classify the probiotics. Most commonly used was separate 
probiotics to bacterial and non-bacterial probiotics. In addition to certain yeast and fungal 
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probiotics, most of the micro-organisms used are bacteria. And according to the property of 
growth, they can be divided to spore-forming and non- spore forming probiotics. Although non-
spore forming Lactobacillus and Bifidobacterium strains predominated initially, spore forming 
bacteria are now used, e.g., Bacillus species. Another method to separate probiotic can be classified 
by the number of strains, the multispecies probiotics or single- species probiotics. The microbial 
composition of probiotic products ranges from a single strain to multi-strain or species 
compositions. The microorganisms used as probiotics which are typically not present in the 
gastrointestinal tract (GIT) of animals are referred to as allochthonous (e.g., yeasts), while the 
microorganism normally present as indigenous inhabitants of the GIT are referred to as 
autochthonous probiotics (e.g., Lactobacillus and Bifidobacterium) (Bajagai et al., 2016). 
 
1.2.2 Characteristics of probiotics 
The mechanisms of action of probiotics as AGP appears to be different. Probiotics help to prevent 
and control GIT pathogens and improve the performance and productivity of production animals 
through varies mechanisms. One of the major determinants of maintaining a healthy GIT is the 
composition of the microbial population and their balance in the GIT. Probiotics can change the 
dynamics of bacteria in the GIT; it may increase the population of beneficial microorganisms 
including Lactobacilli and Bifidobacteria, which then inhibit growth of harmful microorganisms 
by producing inhibiting substances (bacteriocins or organic acids) and by competitive exclusion. 
The reduction in pathogenic microorganisms in the GIT may be attributable to the production of 
antimicrobial substances such as bacteriocins and adhesion of probiotic microbes to the intestinal 
epithelium, thereby excluding pathogens competitively or by including immune system response. 
Probiotics in the intestine may increase enzyme activity resulting in the promote of digestibility of 
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nutrients in diet (Zhang and Kim, 2014). And many experiments proved utilization of probiotics 
increased the villus height, crypt depth, and ratio of villus height to crypt depth thus increasing the 
surface area for nutrition absorption (Bajagai et al., 2016; Palamidi et al., 2016).  
Another essential mechanism of probiotics is to produce the antimicrobial substances in intestinal. 
Many probiotic bacteria, especially lactic acid bacteria producing short chain fatty acids (SCFAs), 
particularly lactic and acetic acids, can inhibit pathogenic bacteria. SCFA reduce the pH in micro-
environment within the intestinal, which can reach to a lethal level for some bacteria (Daskiran et 
al., 2012). Bacteriocin produced by lactic acid bacteria inhibits the growth of pathogenic 
microorganisms by inhibiting cell wall synthesis (Hyronimus et al., 1998). And some probiotics 
can produce other antimicrobial compounds that may inhibit harmful microbes in the GIT (Bajagai 
et al., 2016). According to the immune modulation, administration of probiotics before infectious 
or pathogens colonization play the most important role in gut immunity. Probiotics can improve 
the innate gut immunity through restitution of intestinal barrier function. And diets containing 
probiotics could modulate the host immune response, affect the expression of some anti-
inflammatory cytokine or cell signaling proteins. Probiotics also increase serum immunoglobulin 
levels. A multi-strain probiotic containing L. acidophilus, B. subtilis, and C. butyricum increased 
serum levels of IgA and IgM in chickens (Zhang and Kim, 2014). One famous theory on probiotics 
mechanism is colonization resistance, which can be understood as following: the GIT of neonatal 
birds are colonized with microorganisms, generally originating from the mother, these 
microorganisms provide protection from enteric pathogens. Probiotics could mimic natural 
colonization in neonates, or colonize adult animals, preventing pathogenic organisms from 
colonizing the intestinal mucosa (Bajagai et al., 2016). Several beneficial claims have been 
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established for probiotics, but this evidence is not sufficient. In general, the growth promoting 
effects of probiotics are limited and variable. 
 
1.2.3 Utilization of probiotics in poultry industry 
Probiotics can improve growth performance, gut health, and immune function of broiler chickens 
(Bajagai et al., 2016; Palamidi et al., 2016; Zhang and Kim, 2014). Lactobacillus, Enterococcus, 
Bacillus, and Saccharomyces are the most used probiotics in poultry production (Gaggia et al., 
2016). Probiotics have enhanced the growth rate in broilers better than AGP (avilamycin) (Bajagai 
et al., 2016; Palamidi et al., 2016; Zhang and Kim, 2014), which appeared in body weight (BW) 
gain. And these improvements in growth performance associated with increased feed intake (FI), 
and better feed conversion ratio (FCR), which is one of the modes of actions for improved growth. 
Another reason may be due to the different microbial population in the GIT resulting in increased 
production of SCFA and immune-modulation (Daskiran et al., 2012). Increased growth 
performance has also been related to increased villus height, crypt depth, and the ratio between 
villus height and crypt depth, which improve the absorption of nutrients from the intestine (Bajagai 
et al., 2016; Palamidi et al., 2016). Utilization of probiotics may results in the difference on the 
colonization of the GIT microfloral, which may prevent or control some enteric pathogens, like 
Salmonellosis, Campylobacteriosis, Necrotic enteritis, and coccidiosis (Gaggia et al., 2010; 
Palamidi et al., 2016). Some experiments evaluated the probiotics influence on egg production and 
quality. However, there is no consistent effect on the production and quality of eggs in laying hens. 
In general, probiotics could be a potential alternative to AGP to improve growth rate, have positive 
effects on FI, FCR, affect intestinal histomorphology, reduce intestinal colonization and spread of 
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pathogens, manage the enteric pathogen, but those outcomes from probiotic use are not consistent 
(Bajagai et al., 2016; Daskiran et al., 2012). 
 
1.2.4 Bacillus coagulans 
Spore-forming bacteria, particularly various species from the genus Bacillus, are becoming 
increasingly popular as probiotics for use in animal feed, due to their robustness in withstanding 
high temperature making them easier to handle during manufacture, storage, and transportation of 
feed. Probiotic Bacillus Coagulans (B. coagulans) is a lactic acid-forming bacterial species. It 
exhibits characteristics typical of both genera Lactobacillus and Bacillus, its taxonomic position 
between the families Lactobacillaceae and Bacillaceae was often debated. It was finally transferred 
to the genus Bacillus. B. coagulans is a Gram-positive rod, catalase positive, spore-forming, 
motile, and a facultative anaerobe. It may appear Gram-negative when entering the stationary 
phase of growth. The optimum temperature for growth is 50 °C.  
Many factors make B. coagulans a good candidate for probiotic use; B. coagulans is one of the 
most promising forming lactic acid-producing species. It produces organic acids, possesses the 
capacity to sporulate, and is easily cultured in bulk (Hyronimus et al.,1998). In addition, in the 
spore form, it is more resistant to high temperature, which facilitates the pelleting process used in 
the mass production of probiotic chicken feeds. Seldom study has been carried out on spore 
forming lactic acid-producing bacteria such as Bacillus coagulans as probiotics in broiler chickens. 
First experiments conducted in 1998 by Cavazzoni et al., the newly isolated B. coagulans as 
probiotic compared with no additive and add virginiamycin groups, showed that B. coagulans as 
a probiotic has a growth- promoting, prophylactic effect comparable to that of virginiamycin. 
Hyronimus et al., in 1998 proved Bacillus coagulans can produce a bacteriocin-like-inhibitory 
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substance coagulin. Zhou et al. (2010) evaluated, also, the effect of probiotic via the basal diet on 
growth performance of Guangxi Yellow chickens. It was clear that the dietary administration of 
probiotic (Bacillus coagulans ZJU0616) had beneficial effects on both final body weight and daily 
weight gain of chickens. Another experiment in 2011 proved supplementation of 0.05% and 0.04% 
B. coagulans significantly improved FCR over the 21- 42 days and the full 42 days in broiler 
chickens. However, the ADG during this period decreased. Intestinal microflora Lactobacillus was 
significantly increased on duodenum and cecum in 0.02% and 0.04% B. coagulans group. 
Additionally, the count of E. coli was significantly decreased in duodenum and cecum in 0.02% 
and 0.04% B. coagulans group (Lin et al., 2011). In contrast, Hung et al. (2012) found that dietary 
use of the probiotic B. coagulans reduced the average daily feed intake by 8% in the broiler grower-
finisher phase (days 22–42) with a reduction in FCR by 10%. All in all, B. coagulans has the 
potential to be a probiotic that may control the population of pathogenic microorganisms, further 
may influence on gut histomorphology and hence improve the growth performance of broiler 
chickens.  
 
1.3 Prebiotic 
1.3.1 Classification 
Prebiotics are defined as “non-digestible food ingredients that beneficially affect the host by 
selectively stimulating the growth and/or activity of one or a limited number of bacteria in the 
colon” (Manning and Gibson, 2004). There are three criteria for the classify the dietary substrate 
as a prebiotic: 1) the substrate must not be hydrolysed or absorbed in the stomach or small intestine; 
2) it must be selective for beneﬁcial commensal bacteria in the large intestine such as the 
lactobacillus, biﬁdobacterial; 3) fermentation of the substrate should induce beneﬁcial effects 
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within the host. Most identified prebiotics are carbohydrates and oligosaccharides, according to 
the criteria of prebiotics, most promising prebiotics are non-digestible oligosaccharides, like 
fructo-oligosaccharides, galacto-oligosaccharides. They are found in chicory, barley, wheat, beet 
leaves and belong to plants fructans which are fermented by beneficial bacteria. Grain legumes are 
the most common natural resources of oligosaccharides, which includes raffinose, stachyose, and 
verbascose (Huyghebaert et al., 2011). 
 
1.3.2 Characteristics of prebiotics 
The mechanism of action of prebiotics as alternative AGP is dependent on the nature of the 
compound. As the criteria of prebiotics, they are non-digestible feed ingredients that can have a 
beneficial action because of selective stimulation of the growth or metabolic activity of a limited 
number of intestinal microbiota species, such as lactobacillus, biﬁdobacterial. Thus they may have 
a similar mechanism of action as probiotics. Many actions make prebiotics be a beneficial 
supplements of broiler chickens. Prebiotics affect bifidobacterial proliferation and reduce harmful 
micro-organisms proliferation. It can also help to resistance to gastric acidity, to hydrolysis by 
digestive enzymes and to GIT absorption, fermentation by intestinal microflora. It can also remove 
harmful enzymes and toxic metabolites, effect on the synthesis of Vitamin, organic acids 
(Dankowiakowska et al., 2013; Manning and Gibson, 2004). 
 
1.3.3 Utilization of prebiotics in poultry industry 
The utilization of prebiotic on broiler chickens has not a long history, reports on the impact of 
prebiotics on the growth performance, gut health, activity of intestinal microflora are not 
numerous. Even though the effect is different and depends on the type of prebiotic, there already 
have many research proved the potential of prebiotics as AGP in poultry industry. 
 17 
In 2003, Chen proved that feeding chicory fructans to broiler chickens showed improvement in 
body weight gain, feed conversion ratio, carcass weight and serum cholesterol decrease; 
Additionally, the supplementation of fructans resulted in increase of lactobacilli counts in the 
gastrointestinal tract and Campylobacter and Salmonella decrease. Similar results got from 
experiment with mannan-oligosaccharides that yeast cell wall containing the prebiotic reduced the 
Salmonella concentration in broiler chicks compared with chicks fed non-supplemented diet. For 
mannan-oligosaccharides, no weight gain was observed in turkeys fed two different concentrations 
of inulin and mannan-oligosaccharides, whereas another experiment proved, feeding turkeys a 
standard diet supplemented with MOS, reported an improvement on body weight (Gaggia et 
al.,2010; Dankowiakowska et al., 2013). Enrichment mannan-oligosaccharides in poultry diets 
have stimulating effect on lymphatic tissue of the gastrointestinal tract. Broiler chickens fructo-
oligosaccharides supplemented diet significantly increases the number of bifidobacteria and lactic 
acid bacteria in the cecum and small intestine. Furthermore, population of Clostridium perfringens, 
Escherichia coli and Salmonella are significantly reduced. Fructo-oligosaccharides alleviates the 
effects of caecal epithelial necrosis, also stimulates growth of intestinal villi and crypts in the 
jejunum and iliac colon (Rehman et al., 2007). 
The possible explanation of those variable influence of prebiotics may be related to different dose 
of prebiotic applied, concentration of prebiotics, methods of feeding (in water/ feed, or in ovo 
technology), time and duration of supplements. There still need a lot of work to reach a consistent 
influence of prebiotic on broiler chickens. 
 
1.3.4 Raffinose family oligosaccharides 
The raffinose family of oligosaccharides (RFO) is a trisaccharide composed of galactose, glucose, 
and fructose. It can be easily found in many plants and seeds. Raffinose can be hydrolyzed to 
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galactose and sucrose by a specific enzyme, which is not found in the digestive tract. As the soluble 
carbohydrates, they rank second only to sucrose. As the deficiency of enzyme, RFO cannot be 
broken down and digested in stomach and upper intestine. It can only be fermented in lower 
intestine by specific bacteria. 
Experiment by Bednarczyk et al. (2011) reported a prebiotic effect of in ovo injection with RFO 
on growth performance and concluded that in ovo injection of raffinose could replace AGP as a 
non-antimicrobial enhancer additive. Similar experiment in 2017 proved that supplemented with 
RFO has beneficial effect on gut health, which appears in higher villus height, and increased villus 
height to crypt depth ratio. And this research also claimed including of RFO contributes to higher 
expression on related immune gene (Berrocoso et al., 2017). 
 
1.4 Synbiotic 
Synbiotics are defined as a mixture of probiotics and prebiotics that beneficially affects the host 
by improving the survival and persistence of living microbial dietary supplements in the 
gastrointestinal tract, by selectively stimulating the growth and /or by activating the metabolism 
of one or a limited number of health-promoting bacteria (Huyghebaert et al., 2011). This 
combination would thus combine substrate and bacteria. The acquisition of data on the efﬁcacy of 
synbiotic products as feed additives in poultry needs further investigation. However, results on in 
vivo trials are promising, showing a synergistic effect coupling probiotics and prebiotics in the 
reduction of food-borne pathogenic bacterial populations (Gaggia et al., 2010). Awad et al. (2009) 
evaluated the effect of a symbiotic product (a combination of E. faecium, a prebiotic derived from 
chicory, and immune modulating substances derived from sea algae) on broiler chickens. The 
results showed significant increase in BW, average daily gain, carcass yields percentage, and FCR, 
whereas no increase in organ weight was found, with a reception for the small intestine; This 
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research also reported a significant increase in the villus height in both duodenum and ileum (Awad 
et al., 2009). 
 
1.5 In ovo technology 
1.5.1 History of in ovo technology 
Recent research tends to eliminate the unwanted effects of many factors that may affect the action 
of supplements. A promising method that gives positive results is the method of administration 
supplements by injection in ovo. The in ovo technology is based on injection of substances with 
various activity to the eggs air chamber or directly into the growing embryo (Bednarczyk et al., 
2011). In ovo technology was designed in the 1980s in the United States, in order to vaccinate 
chicks against Marek’s disease, and later against the Gumbro disease, Newcastle Disease. Due to 
the ability of late-stage embryos and fetuses to support immune responses to viral and bacterial 
antigens, used the in ovo injection for the Marek’s disease vaccine in embryonic chickens have 
greater protective indices when vaccinated at embryo stage (the 16th to 20th days of incubation; 
Vaccination at the 18th day revealed the greatest protection) compared to those vaccinated at hatch 
(P < 0.05), while having no effect on hatchability (Sharma and Burmester, 1982).   
Because of the success with in ovo vaccination, in ovo technology has a wider application with the 
injection of various biologics, aims at including for example: stimulation of beneficial bacterial 
profile in the colon of chicken, stimulation of immunological response, stimulation of embryonic 
development, teratogenic effects testing, selection for sexual phenotype, injection of genetically 
modified cells, etc (Dankowiakowska et al., 2013). The use of feed additions such as prebiotics 
and probiotics or their combination- synbiotics influences health and chicken performance. Their 
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administration in ovo could have an advantageous impact on early development of immunological 
system in broiler chickens (Roto et al., 2016). With the development of this technology, there are 
more issues on this technique need concern, like the site of injection, solution injected, age of 
injection, and method of injection. In the late stage of embryonic development, there are five 
regions through which an in ovo injection may be delivered: the air cell, the allantoic membrane, 
the amniotic fluid, the yolk, and the embryo. Recently, the most acceptable injection time was late-
term avian embryo with delivery to the amniotic fluid, which developed by Uni and Ferket (2003). 
And variable in ovo studies has focused on different recommended location and age as given by 
Uni and Ferket (2003), what supplement is injected, such as nutrients, hormones, 
immunostimulants or other biologics, attempting to promote growth and stimulate the immune 
system. 
 
1.5.2 Utilization of in ovo technology 
Numerous studies have been conducted investigating the efficacy of in ovo injection of various 
biologics in poultry, including nutrient supplements. Carbohydrate, proteins, and amino acids, 
vitamins, or other modulators are most common injection material. In ovo supplementation of 
carbohydrates might help in improving the growth of late-term embryos and chicks. When 
inoculated eggs with carbohydrates (maltose, sucrose, and dextrose), the results showed that the 
additional energy source enhanced the development of goblet cells and increased the villi surface 
area in the intestines. The same carbohydrate mixture was applied again in different studies; both 
indicated increased body weight and increased liver glucose at hatch (Smirnov et al., 2006). In ovo 
glucose could modulate humoral-related immunity, while fructose or ribose might help in 
improving the cellular immunity in broiler chickens (Bhanja et al., 2015). The results of the 
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influence oligosaccharides on the post embryonic development of organisms may provide a good 
basis to conduct further research to improve immune response, higher productivity, and reduce use 
of antibiotics in animal production. Experiments of Ohta et al. (1999) injected amino acids into 
the yolk sac at both 0th and 7th days; both injections resulted in increased body weight with no 
effect on hatchability. And the addition of amino acids stimulated the utilization and synthesis of 
amino acids with a simultaneous decrease in the degradation of amino acids (exact biochemical 
degradation not specified), when the amino acids injected were identical to those naturally 
occurring in the egg. Recently experiment conducted by Calik et al. (2016) proved combined intra-
amniotic and dietary symbiotic treatment improved broiler intestinal integrity and increased cecal 
beneficial bacteria population. The villus height and goblet and proliferating cell nuclear antigen 
positive cell counts were positively influenced by the intra-amniotic and dietary symbiotic 
treatments. This treatment also increased lactobacillus colonization and decreased coliform 
population in broiler cecum (Calik et al., 2016). In summary, the experimental studies of injections 
with carbohydrate, amino acids, synbiotic indicate the potential benefits for the commercialization 
of in ovo injection of nutrients (Roto et al., 2016). 
 
1.5.3 Advantages and limitations of the in ovo technology 
In ovo technology, as one of the most essential measures of early nutrition programming, own its 
premium advantages and shortcomings. Earlier immunity against disease with minimal 
interference from maternally-derived antibodies. By in ovo inoculation, the chick has the best 
possible start when it hatches, and better disease resistance from day one. Minimal chick handling, 
which reduces chick stress, improves bird health, allowing chicks to be transported to the farm 
faster and into the ideal grow-out environment.  However, there still exists some limitation of this 
 22 
technology. First, it is economically suitable only for large-volume hatcheries. For this technology, 
it hard to make sure the exact site of injection, and due to variable size of each embryo in eggs, it 
enhanced the damage possibility when using in ovo injection machine. If operation by manual, it 
is also difficult to control the time, environment and other conditions. Most essential point is there 
are no consistent results on the ideal time, site, and volume of in ovo injection. Different injection 
material has specific optimal injection procedure. It is critical to evaluate best in ovo injection 
regular pattern. More research on in ovo injection technology will provide a convenient and 
economic method on the development of early nutrition programming. 
 
1.6 Hypothesis of the study 
The selected probiotic, prebiotic, and synbiotic have the desirable nutritional profile and immune 
function to be used as alternative growth promoters when utilized by in ovo technology on broiler 
chickens for early nutrition programming. 
 
1.7 Justification of study 
A healthy gastrointestinal tract is crucial for optimum performance, better feed efficiency and 
overall health of poultry. Due to the claimed public health concerns, use of antibiotics as growth 
promoters in the chicken feed is banned or regulated in several jurisdictions. Therefore, it is 
necessary to find alternatives to AGP. Probiotics, prebiotics, and synbiotics are being evaluated as 
effective alternatives to AGP to improve growth performance and nutrient digestibility, balance 
intestinal microflora, promote immune function, and improve the intestinal morphology of poultry. 
Probiotic Bacillus Coagulans is a lactic acid-forming bacterial species. It exhibits characteristics 
typical of both genera Lactobacillus and Bacillus, and it was finally transferred to the genus 
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Bacillus in the seventh edition of Bergey's. Many factors make B. coagulans a good candidate for 
probiotic use; It produces organic acids, possesses the capacity to sporulate, and is easily cultured 
in bulk. In addition, in the spore form, it is more resistant to heat, which facilitates the pelleting 
process used in the mass production of probiotic chicken feeds (Hyronimus et al., 2000). Raffinose 
family oligosaccharides are considered to be prebiotic compounds because they are not hydrolyzed 
in the upper gastrointestinal tract and are able to alter the colonic microflora favorably. The 
synbiotic is the mixtures of B. coagulans and raffinose, thus combine bacteria and substrate.  
Early supplements application, especially in ovo technology, represent a means to take advantage 
of the crucial time and promote early colonization of beneficial microbiota in order to stimulate 
intestinal and immune system development. It is critical to determine the injection time and size. 
According to the patent of Uni and Ferket (2003), the ideal injection time is 17 d of incubation egg 
on the amniotic fluid. After hatch, raising 42 d to observe the growth parameter and health 
condition of different stage broiler chicken. 
 
1.8 Objective of the study 
The primary objective of this study was to evaluate the growth performance of broilers with in ovo 
injection of probiotic, prebiotic, and synbiotic. Secondly, to explore the effects of in ovo 
administration on gut health parameters, and to compare the extent of these influence.   
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CHAPTER 2: METHODS 
 
 
2.1 Materials and Methods 
Egg incubation was conducted in the Animal Nutrition Laboratory of University of Hawaii at 
Manoa (Honolulu, HI). Growth performance was conducted at the Small Animal Facility (SAF) 
of UH Manoa. The study was conducted after approval by the Institutional Animal Care and Use 
Committee and following the Research Policy of UH Manoa.  
 
2.2 Experimental design and egg incubation 
275 fertile eggs (Cobb 500) from the 35-week breeding flock was obtained from a commercial 
hatchery (Asagi Hatchery Inc., Honolulu, HI) at 17th day of incubation. On arrival, the eggs were 
weighed and numbered and incubated at 37.5oC and relative humidity of 58% in an incubator 
(GQF incubator, Savannah, GA). After the eggs are acclimatized in the incubator for >8 hours, 55 
eggs were randomly assigned from different weight groups to each treatment. The eggs were 
numbered for each treatment groups and were randomly allocated to 5 replicates of each of 5 
treatments by location on the setter trays. The eggs were transferred on d 19 to hatcher set at 37oC 
and relative humidity 75% following the instructions for pre-set hatcher (GQF incubator, 
Savannah, GA). Each replicate group of eggs from setter was again randomly assigned to different 
hatcher trays separated by divider. After hatching, chicks from each treatment was weighed and 
tagged. Depending on the hatch, 48 chicks from each treatment was moved to the Small Animal 
Facility of the University of Hawaii at Manoa (Honolulu, HI) and randomly allocated to 6 replicate 
pens (8 chicks/pen). The whole process of the trial is showed in Figure 1. 
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Figure 1. Schematic diagram of the whole experimental trial 
 
 
2.3 In ovo injection 
For in ovo injection, each replicate group of eggs was taken out for injection in a biosafety cabinet 
and placed out of incubator for less than 15 minutes. At d 17.5 broad end site of all eggs was 
disinfected with 10% povidone-iodine solution and then a tiny punch hole (shell perforation) was 
made with a stabbing awl with a fixed depth of 1mm made with a pipette sheath/sleeve. After 
every punch, the tip of the awl was disinfected with 70% ethanol and wiped with sterile gauze. 
Each egg was injected in their amniotic sac using blunt tip 21 gauze sterile needle inserted to 1.1-
inch length from the longest axis through the broad end and passing beyond the air sac to amnion 
fluid. All the eggs were sealed using non-toxic parafilm/glue. Probiotic Bacillus coagulans ATCC 
7050 (KWIK-STIK unit contains lyophilized pellet) were bought from Microbiologics Inc, MN, 
USA. All together there were five treatment groups: 1) No-injection group with intact shell, 2) 0.5 
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ml 0.85% Normal Saline, 3) Probiotic (B. coagulans) (4 × 106 cfu/g) in 0.5 ml 0.85% Normal 
Saline, 4) Prebiotic (4.5 mg RFO) in 0.5 ml 0.85% Normal Saline, and 5) Synbiotic (4 × 106 cfu/g 
B. coagulans + 4.5 mg RFO) in 0.5 ml 0.85% Normal Saline.  
 
2.4 Hatchability, growth performance, and organs relative weight 
After hatch, the unhatched eggs were counted and opened to check for the cause of death of 
embryo. Hatchability was noted for all replicate and was being subjected to statistical analysis 
after arcsin square root transformation. The weighed and tagged chicks were placed randomly in 
30 floor pens (7 birds per pen), making 6 replicates of each treatment. Birds in all the floor pens 
were raised under standard commercial broiler rearing environment (temperature, humidity, and 
light). The temperature in the first wk was maintained at 35oC and gradually decreased to 28oC by 
the end of the third week. All birds were fed with a commercial corn-soybean meal-based pellet 
diet during the starter 21-day post-hatch trial period (Table 1), and finisher 21-42 day post-hatch 
trial period (Table 2). The diet met or exceeded the nutritional requirements of broiler chickens 
(standard guidelines of breeder) and birds had unrestricted access to feed and water at all times. 
Body weight and feed consumption of the birds were measured by pen at 7, 14, and 21 d of age, 
and ADG, ADFI, and FCR were calculated from these data by period and cumulatively. Feed 
wastage was recorded daily, and the feed consumption was adjusted for wastage and bird mortality. 
On d 21, d 42, 6 birds per treatment (1 bird per pen) were randomly chosen for the determination 
of organ weights and were dissected after euthanizing with CO2 gas. The weight of breast muscle, 
drumsticks, gizzard, and proventriculus were recorded, and the relative weight (% of live body 
weight) was calculated. 
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Table 1. Ingredient composition of starter diet fed to the broilers in the study 
 
Item 
Inclusion 
level 
Active drug ingredients 
Amprolium 0.0125% 
Guaranteed analysis 
Crude Protein (Min) 22.00% 
Lysine (Min) 1.00% 
Methionine 0.45% 
Crude Fat (Min) 3.50% 
Crude Fiber (Min) 4.00% 
Calcium (Ca) (Min) 0.90% 
Calcium (Ca) (Max) 1.40% 
Phosphorus (P) (Min) 0.60% 
Salt (NaCl) (Min) 0.30% 
Salt (NaCl) (Max) 0.80% 
Total Selenium (Se) (Min) 
0.60 
ppm 
Total Selenium (Se) (Max) 
0.72 
ppm 
Phytase (A. Oryzae) (Min) 
227 
FYT/LB 
One phytase unit (FYT) liberates one micromole of inorganic phosphorus per minute 
from sodium phytate at pH 5.5 and 98.6 F. Contains a source of phytase, Ronozyme 
HiPhos GT, which can hydrolyze phytate increasing the digestibility of phosphorus in 
diets containing phytin-bound phosphorus. 
 
 
 
 
 Table 2. Ingredient composition of finisher diet fed to the broilers in the study 
Item 
Inclusion 
level 
Active drug ingredients 
Amprolium 0.0125% 
Guaranteed analysis 
Crude Protein (Min) 18.00% 
Lysine (Min) 0.86% 
Methionine 0.40% 
Crude Fat (Min) 3.50% 
Crude Fiber (Min) 5.00% 
Calcium (Ca) (Min) 0.90% 
Calcium (Ca) (Max) 1.40% 
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Phosphorus (P) (Min) 0.50% 
Salt (NaCl) (Min) 0.20% 
Salt (NaCl) (Max) 0.70% 
Total Selenium (Se) (Min) 0.65 ppm 
Total Selenium (Se) (Max) 0.78 ppm 
Phytase (A. Oryzae) (Min) 227  FYT/LB 
One phytase unit (FYT) liberates one micromole of inorganic phosphorus per minute 
from sodium phytate at pH 5.5 and 98.6 F. Contains a source of phytase, Ronozyme 
HiPhos GT, which can hydrolyze phytate increasing the digestibility of phosphorus in 
diets containing phytin-bound phosphorus. 
 
 
2.5 Ileum Mucosa Histology 
On d 0, ileal samples (n=3/treatment) and on d 7 & 21 (n=6/treatment) (1 bird per cage) after 
euthanasia was collected in fixatives solution for histomorphological study. Briefly, a section of 
approximately 1 cm of small intestine (between 1 cm posterior to the Meckel’s diverticulum and 
1 cm anterior to ileocecal junction) was collected in 2 replicates for each fixative. Ileal samples 
were stored in 1:10 volumes of each fixative. The fixatives were 10% neutral buffer formalin 
(NBF) kept in ice bath. The samples were fixed overnight. NBF samples were transferred to 70% 
ethanol. The samples fixed in NBF were sent to Histo-core at JABSOM for embedding and staining 
with Hematoxylin and Eosin (H&E). A total of 6 intact, well-oriented crypt-villus units were 
selected in triplicate (18 measurements for each sample). An upright light microscope (Olympus 
BX43, Olympus Co, Tokyo, Japan ) was used for histological analysis. Villus height was measured 
from the tip of the villi to the villus crypt junction, and crypt depth was determined as the depth of 
the invagination between adjacent villi. Measurement of villus height and crypt depth was 
performed using image processing and analysis system of the software, INFINITY ANALYZE, 
specialized for the microscope. The objective magnification was used at 20X, 10X, and 5X at 
hatch, and 7 d post hatch for ileum histological slides for better measurement. 
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2.6 RNA Extraction, Reverse Transcription, and Real-Time Quantitative PCR 
Three sections of approximately 0.5 cm of ileum were collected from 6 birds per treatment (1 bird 
per replicate). Ileum sections were collected and snap frozen in liquid nitrogen, later stored at 
−80◦C until total RNA isolation. For RNA isolation, the tissue was removed from RNA later 
solution to a micro-tube. Approximately 50-100 mg of the tissue were be homogenized directly in 
TRIzol RNA isolation reagent (Invitrogen, Carlsbad, CA). Total RNA was extracted using 1 mL 
of TRIzol per sample according to the manufacturer’s instructions. After RNA extraction, RNA 
concentration was measured with NanoPhotometer® P330 (IMPLEN, Los Angeles, CA). RNA 
quality was determined with the Agilent 2100 Bioanalyzer (Agilent Technologies, Massy, France). 
The synthesis of first- strand cDNA was performed by reverse transcription of 1 µg total RNA (20 
l reaction of RT mixture) using High-Capacity cDNA Reverse Transcription Kit (Applied 
Biosystems, Foster City, CA). cDNAs were further diluted with nuclease free-water (1:25) and 3 
l per qPCR reaction was used for gene expression. PowerUp SYBR Master Mix (Applied 
Biosystems, Foster City, CA) on a StepOne Plus real-time PCR system (Applied Biosystems, 
Foster City, CA) was used for gene expression analyze. Each 10 l of PCR reaction mixture of 
consisted of 5l PowerUp SYBR Green Master Mix, 1 l of each forward and reverse primers, 
and 3l of cDNA.  PCR reactions were carried out following standard cycling mode. Melting curve 
was also generated to confirm the sequence-specific PCR products. The cycle threshold (Ct) value 
was determined, and the abundance of gene transcripts was analyzed using the ∆∆Ct method with 
glyceraldehyde 3-phosphate dehydrogenase (GAPDH) as the reference gene (Berrocoso et al., 
2017), and additionally, we were using Beta-actin (β-actin), TATA-Box Binding Protein (TBP) as 
a reference and normalization gene. The target genes were analyzed in duplicates and expression 
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level was determined using Ct value following standard curve method after normalization with 
TBP. 
Innate and adaptive immunity stimulation due to probiotics and prebiotics inclusion will be 
determined measuring gene expression of respective immune cell markers. The CD56 gene marker 
for NK-cells, TLR4 gene marker for macrophage, IL-10 gene marker for anti-inflammatory 
cytokines and IL-1β gene marker for pro-inflammatory cytokines were amplified to see their 
relative abundance which can explain about the status of innate immunity and any ongoing 
inflammation. In order to access the influence of the treatment on adaptive immune response, the 
CD3 (membrane protein expressed in T cell at all stage of development) and ChB6 (also known 
as Bu-1 is expressed on early and mature B cells) gene markers of T-cell and B-cell were amplified 
using the respective primers (Table 3). Fold change for each gene was calculated using the 2-Ct 
method. Data for fold change were presented as mean ± standard error. Values were subjected to 
one-way analysis of variance (ANOVA) followed by Tukey-Kramer test for multiple mean 
comparison to determine significance at P < 0.05 on a SAS platform. 
 
2.7 Statistical analysis 
Data were statistically analyzed using the MIXED procedure of SAS (SAS v9.2, SAS Institute 
Inc., Cary, NC) to compare the test variables. Means were separated by Tukey test using pdmix 
macro of SAS and were declared significant if P < 0.05. 
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              Table 3. Nucleotide sequences of primers used in Real-time qPCR analyses 
   
Gene Primer Sequence 
Genbank 
Accession 
number 
Amplicon 
Size (bp) 
Immune cell:  
related genes: 
    
CD3 Forward 5'-GGACGCTCCCACCATATCAG-3' NM_205512 180 
 Reverse 5'-TGTCCATCATTCCGCTCACC-3' 
 
 
 
 
  
CD14 Forward 5'-TGGACGACTCCACCATTGAC-3' 
5'-CCATCTCCTGCACCTGAGTG-3' 
 
NM  001139478 
 
132 
  Reverse '- - ' 
 
  
CD45 Forward 5'-TATTCTTGGTGTTCTTGATTGTTGTG-3' NM_204417 120 
 Reverse 5'-CTGCTACAAGGCTGATGACTTCA-3' 
  
CD56(NCAM1) 
(NCAM1) 
Forward 5'-GTTCATGAGCAGAGGGTGCT-3' NM  001242604 196 
 Reverse 5'-ACATGGCCTGGATGATGCAA-3' 
  
ChB6 (Bu-1) Forward 5'-TACTTTGTCGGCCGAGTGTC-3' NM  205182 197 
 Reverse 5'-AGTCTGCAGTTCCATTGGGG-3' 
  
TLR4 Forward 5'-AGTCTGAAATTGCTGAGCTCAAAT-3' NM_001030693 190 
 Reverse 5'-GCGACGTTAAGCCATGGAAG-3' 
  
Cytokine: 
 
 
  
IFN-gamma Forward 5′-CTGAAGAACTGGACAGAGAG-3' 
 
NM  205149.1 
 
264 
  Reverse 5′-CACCAGCTTCTGTAAGATGC-3' 
 
  
IL-1 Forward 5′-CGCTTCATCTTCTACCGCCT-3' NM_204524 144 
 Reverse 5′-GATGTTGACCTGGTCGGGTT-3′ 
  
IL-4 Forward 5′-TGTGCCCACGCTGTGCTTACA-3' 
5”CTTGTGGCAGTGCTGGCTCTCC3” 
 
NM  001030693 
 
155 
  Reverse 5′- -3' 
 
  
IL-10 Forward 5′-TGTCACCGCTTCTTCACCTG-3′ NM_001004414 105 
 Reverse 5′-CTCCCCCATGGCTTTGTAGA-3′ 
  
Reference: 
 
 
  
GAPDH Forward 5'-AGCTTACTGGAATGGCTTTCCG-3' NM_204305 122 
  Reverse 5'-ATCAGCAGCAGCCTTCACTACC-3'     
TBP Forward 5'- TAGCCCGATGATGCCGTAT-3' NM_205103 147 
 Reverse 5'- GTTCCCTGTGTCGCTTGC-3'   
−actin Forward 5'- GAGAAATTGTGCGTGACATCA-3' X  00182 152 
 Reverse 5'- CCTGAACCTCTCATTGCCA-3'   
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Chapter 3 Results 
 
3.1 Hatchability 
The in ovo injection did not affect (P > 0.05) hatchability of chicks across the treatments (Table 
4). 
 
Table 4. Effects of in ovo injection on hatchability 
 
 
Non-
injected 
Normal 
Saline 
B. 
coagulans RFO 
B. 
coagulans+RFO 
Total eggs 51 49 49 49 49 
Hatched eggs 49 45 45 42 46 
Hatchability  0.96 0.91 0.91 0.85 0.93 
 
 
3.2 Effect of in ovo injection on growth performance and relative organs weight 
There was no significant effect of treatments on body weight, average daily gain and feed intake 
of broilers (Table 5). However, birds from normal saline treatment had significantly better (P > 
0.05) feed efficiency and RFO group had the poorest in the first week of post-hatch period. The 
results of injection of B. coagulans, RFO, and B. coagulans + RFO on the relative weights of 
digestive organs are summarized in Table 6. On d 21 and d 42 of age, the relative weight of the 
proventriculus, drumstick, breast muscle, and gizzard were not affected (P > 0.05) by inoculation 
supplements. 
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Table 5. Effects of in ovo injection on growth performance of broiler chickens 
 
  
Non-
injected 
Normal 
Saline 
B. coagulans   RFO 
B. coagulans+ 
RFO 
SEM (n 
= 6) 
P-value 
Initial 
BW 
44.2 45.1 44.7 44.2 44.6 1.33 0.7 
d 0 to 7        
ADG, g 14.8 15.7 15.5 15 15.7 0.78 0.225 
ADFI, g 19.6 20.2 20.3 21.6 20.6 1.6 0.319 
FCR 1.325 1.29 1.306 1.441 1.317 0.091 0.059 
d 7 to 
14 
       
ADG, g 44.7 45.2 45.5 44.8 45.8 1.71 0.76 
ADFI, g 65.5 69.1 65.7 66.8 67.2 5.13 0.754 
FCR 1.469 1.53 1.441 1.49 1.466 0.096 0.59 
d 14 to 
21 
       
ADG, g 75.7 76.7 77.2 76.2 77.2 4.468 0.971 
ADFI, g 119.4 119.5 118.2 120.6 119.2 8.319 0.993 
FCR 1.581 1.558 1.531 1.585 1.544 0.081 0.744 
d 21 to 
28 
       
ADG, g 78.3 82 81.2 82.7 81.5 6.359 0.799 
ADFI, g 159.2 174.5 172.4 165.9 169.6 22.583 0.79 
FCR 2.032 2.137 2.125 2.009 2.073 0.226 0.83 
d 28 to 
35 
       
ADG, g 80.2 77.3 83 86.2 85.7 9.145 0.311 
ADFI, g 189.8 201.7 200.6 191.6 200.9 29.132 0.918 
FCR 2.369 2.615 2.417 2.23 2.344 0.27 0.198 
d 35 to 
42 
       
ADG, g 89.7 95.5 89.5 96.3 94.2 11.591 0.757 
ADFI, g 204 229.9 226.1 223.8 218.3 32.418 0.676 
FCR 2.29 2.448 2.522 2.335 2.347 0.364 0.804 
BW: Body weight; ADG: Average daily gain; ADFI: Average daily feed intake; FCR: Feed conversion ratio 
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Table 6. Effects of in ovo injection on relative weight (% of BW) of liver, gizzard, 
proventriculus, drumsticks 
 
 
Non-
injected 
Normal 
Saline 
B. 
coagulans 
  RFO 
B. 
coagulans+ 
RFO 
SEM (n 
= 6) 
P-value 
d 21        
Liver, % 2.83 2.78 2.68 2.82 2.77 0.0034 0.942 
Gizzard, % 1.95 2.16 2.07 2.01 1.92 0.00222 0.339 
Proventriculus, 
% 
0.5 0.57 0.61 0.53 0.51 0.00118 0.523 
Drumsticks, % 8.34 8.17 8.2 8.06 8.32 0.00484 0.848 
d 42        
Liver, % 2.53 2.04 2.2 2.22 2.45 0.0035 0.132 
Gizzard, % 1.42 1.44 1.27 1.58 1.55 0.00269 0.324 
Proventriculus, 
% 
0.36 0.39 0.4 0.36 0.46 0.0009 0.352 
Drumsticks, % 8.92 9.86 9.47 9.37 8.86 0.00826 0.23 
 
 
3.3 Effects of In ovo injection on ileum mucosa morphology of chickens 
At d 7 of age, ileum villus height, crypt depth, and villus height: crypt depth ratio of prebiotic 
groups were significantly better than other treatments (P < 0.05) (Figure 2; Table 7). On d 7 post-
hatch, probiotic group had better villus height to crypt depth ratio, which suggests about better 
intestinal health, but its impact on growth may not be evident in healthy flock maintained in 
standard condition. 
 
Figure 2. Effects of in ovo injection on ileum mucosa morphology of chickens at 7 d of age 
Images were separately captured with light microscope (Olympus BX43, Olympus Co, Tokyo, Japan) at 
10 X, 20 X magnification. a: villus ehight; b: crypt depth; a/b: villus height to crypt depth ratio. 
 35 
              
 
Table 7. Effects of in ovo injection on ileum mucosa morphology of broiler chickens. 
 
 
Non-
injected 
Normal 
Saline Probiotic Prebiotic Synbiotic 
SEM 
(n= 6) P-value 
VH 1230.1 1183.9 1237.8 1273.5* 1141.2 0.113 0.007 
CD 196.1 179.1 198.7 156.1* 184.1 0.033 0.001 
VH/CD 6.49 6.95 6.29 8.46* 6.28 0.001 <0.001 
VH: villus height (m); CD: crypt depth (m); VH/CD: villus height to crypt depth ratio 
 
 
3.4 Effect of in ovo injection on immune related gene expression in ileum tissue 
IL4, a cytokine had significantly higher expression (P < 0.001) in the probiotic group’s ileum 
sample on d 0 (Figure 3A). The expression of IL10, an anti-inflammatory cytokine was 
significantly higher (P < 0.05) in Normal saline and probiotic group’s ileum sample on d 7 (Figure 
3B). SGLT1 had significantly higher (P < 0.05) expression on No-injection and probiotic 
treatments, while prebiotic and synbiotic group had lower expression (Figure 3B). 
 
Figure 3A, 3B. Effects of in ovo injection on immunity of small intestine of broilers 
Total RNA was extracted from the small intestine of broilers at hatch day and 7 d of age. The expression 
of each gene was examined using RT-qPCR and expressed as ratio to TBP, with the level being set to 1 in 
broilers treated without injection in each gene. A: Effect of in ovo injection on cytokine IL4 on hatch day. 
B: Effect of in ovo injection on anti-inflammatory cytokine IL10, and SGLT1 on 7d. ∗ indicates P < 0.05.  
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Chapter 4 Discussion 
 
4.1 Growth performance 
In ovo administration of B. coagulans, RFO, B.coagulans +RFO had no effect on the body weight, 
relative weight of the liver, proventriculus, gizzard, or drumsticks. Similarly, Berrocoso et al. 
(2017) reported that in ovo injection of RFO did not have a significant effect on d 21 broilers. Both 
experiments proved in ovo procedure did not influence hatchability. Feed efficiency was not much 
influenced by treatments, but it showed a strong tendency that birds from normal saline treatment 
had significantly better (P > 0.05) feed efficiency and RFO group had the poorest in the first week 
of post-hatch period. However, Hung et al. (2012) reported that dietary B. coagulans significantly 
improved FCR throughout the whole 42 days compared with negative control. It demonstrates that 
different supplementation methods and amount on B. coagulans may change their influence on 
broiler chickens. In general, RFO treatment in this experiment shows relatively negative trend in 
BW, FCR. There is evidence of negative effects on animal health and productivity from the use of 
RFO. The possible reason may be the raffinose series oligosaccharide remain undigested in the 
lower gut, can only be fermented by intestinal bacteria and release gases, due to the absence of a-
galactosidase in the upper GIT of monogastric animal (Iji and Tivey, 1998). Including of RFO in 
diets may influence the absorption of diets energy value. Moreover, the digestion of raffinose may 
also alter the osmotic differences between the mucosa and plasma, and this may account for the 
diarrhea observed in animals on diets with high level of legume seeds (Saini et al., 1988).  
 
4.2 Gut health 
 38 
On d 7 post-hatch, RFO group had better villus height to crypt depth ratio, which suggests about 
better intestinal health. But when we go back to Berrocosa et al. (2017) experiment, they reported 
that in ovo injection RFO with an increasing dose increased (P < 0.01) the villus height on hatch 
day, and increased the villus height and villus height to crypt depth ratio (P < 0.05) at 21 d of post 
hatch. Therefore, the injection of RFO affected the ileum mucosa morphology of chickens 
differentially depending on stages of growth and concentration of RFO. Gut morphology and 
function determined the efficiency of digestion and absorption of nutrients, which impact growth 
of broiler chickens. Villus height, crypt depth, and villus length to crypt depth ratio are good 
indicators for functional capacity of the intestine (Fasina and Olowo, 2013). It has been proved 
that higher villus height is associated with a well-differentiated intestinal mucosa with high 
capacity of digestive and absorption. And deeper crypt depth represents on the faster tissue 
turnover and have the potential of higher demand for new tissue (Berrocoso et al., 2017). However, 
in the current study, the improvement in the development of the ileum mucosa, as was measured 
by villus length and villus height/crypt ratio, had no effect in improving growth performance from 
0 to 7 d post hatch, indicating that the measure of intestinal morphology such as villus length and 
villus height/crypt ratio does not necessarily translate into improved growth performance, and its 
impact on health flock are not evident. 
In this study, injection of B. coagulans upregulated IL4 mRNA expression on hatch day ileum 
tissue. IL4 is a cytokine that helps in the differentiation of helper T cells to Th2 cells, stimulates 
proliferation of activated B- cell and T-cell, and induces the differentiation of B cells into plasma 
cells, which is a key regulator in humoral and adaptive immunity. And the presence of IL4 in 
extravascular tissue promoted alternative activation of macrophages into M2 cells and inhibited 
classical activation of macrophages into M1 cells. The higher expression of IL4 proved in ovo 
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injection of B. coagulans could boost early immunity. On d 7 post-hatch, expression of cytokine 
IL10 in the ileum in normal saline and probiotic groups were significantly higher (P < 0.05); As 
an anti-inflammatory cytokine, IL10 can impact on immunoregulation and inflammation by 
downregulation the expression of Th1 cytokines, and co-stimulatory molecules on macrophages. 
It also enhances B cell survival, proliferation, and antibody production. In ovo Supplementation 
with B. coagulans showed significantly high IL10 expression on 7 d ileum sample proved that in 
ovo injection of B. coagulans did has the beneficial effect on immune function in poultry. 
However, this beneficial effect cannot reflect in the performance of healthy broiler chickens. 
Sodium/glucose cotransporter 1 (SGLT1) expressed significantly higher (P < 0.05) in Non-
injection and probiotic groups, while prebiotic and synbiotic treatments had lower gene expression. 
Maybe early injection of RFO has some role in controlling blood glucose, and this function may 
also related with RFO cannot digested in the lower gut.  
 
4.3 Conclusion  
In conclusion, although in ovo injection of B. coagulans, RFO, B.coagulans +RFO did not 
significantly influence growth performance, RFO supplementation enhanced the ileum mucosa 
morphology, which are indicators of improved gut health. In ovo injection of B. coagulans 
improved growth performance, even not significant, and enhanced immune response indicators in 
the small intestinal, which would be beneficial for gut health. The combination of probiotics and 
prebiotics did not show some significant impact on broiler chickens. However, it is interesting to 
find that in ovo injection of normal saline also enhanced gut immunity. Thus, in ovo injection of 
B. coagulans can be a potential early nutrition programming strategy to improve gut development 
and immune function of broiler chickens. 
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